Clinical characteristic and survival outcomes of patients with advanced NSCLC according to KRAS mutational status in the French real-life ESME cohort

Autor: Thomas, Q.D., Quantin, X., Lemercier, P., Chouaid, C., Schneider, S., Filleron, T., Remon-Masip, J., Perol, M., Debieuvre, D., Audigier-Valette, C., Justeau, G., Loeb, A., Hiret, S., Clement-Duchene, C., Dansin, E., Stancu, A., Pichon, E., Bosquet, L., Girard, N., Du Rusquec, P.

Publikováno v: In ESMO Open June 2024 9(6)

Reduced risk of secondary primary extra pulmonary cancer in advanced/metastatic lung cancer patients treated with immune checkpoint inhibitors

Autor: Heudel, P.E., de Montfort, A., Debieuvre, D., Chouaid, C., Carton, M., Audigier-Valette, C., Filleron, T., Chabaud, S., Stancu, A., Quantin, X., Hiret, S., Bosquet, L., Blay, J.Y.

Publikováno v: In Lung Cancer August 2023 182

Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial

Autor: Stahel, R., Hiltbrunner, A., Pardo-Contreras, M., Gasca-Ruchti, A., Giacomelli, N., Kammler, R., Marti, N., Pfister, R., Piguet, A.C., Roux, S., Troesch, S., Schneider, M., Schweri, R., Zigomo, I., Tsourti, Z., Zygoura, P., Tsouprou, S., Kassapian, M., Vervita, K., Dimopoulou, G., Andriakopoulou, C., Morin, F., Amour, E., Mariaule, G., Archirel, N., Fernandez, M., Pereira, E., Benito, L., Lopez, K., Hernández, A., Chinchen, S., Jurkovic, H., Livingstone, A., Mitchell, J., Walker, M., Mitchell, P., Ng, S., Steer, C., Briscoe, K., Saqib, A., Abdi, E., Houghton, B., O’Byrne, K., Chittajallu, B.R., Hughes, B.G., Black, A., Nackaerts, K., Werner, H., Gervais, R., Zalcman, G., Vaylet, F., Merle, P., Monnet, I., Moro-Sibilot, D., Molinier, O., Girard, N., Souquet, P.-J., Barlesi, F., Debieuvre, D., Senellart, H., Poudenx, M., Dixmier, A., Pouessel, D., Cadranel, J., Lena, H., Quoix, E., Friard, S., Audigier-Valette, C., Mazieres, J., Pichon, E., Faehling, M., Kokowski, K., Kirchen, H., Griesinger, F., Tufman, A., De-Colle, C., de Langen, J., González Larriba, J.L., Insa, A., Majem, M., Massutí, B., Pulla, M.P., Aix, S.P., Villanueva, N., Vivanco, G.L., Andrade, J., Curioni-Fontecedro, A., Franks, K., Califano, R., Peters, S., Pujol, J.-L., Dafni, U., Dómine, M., Popat, S., Reck, M., Becker, A., Insa Mollá, A., López Vivanco, G., Madelaine, J., Provencio Pulla, M., Roschitzki-Voser, H., Ruepp, B., Stahel, R.A., Le Pechoux, C., De Ruysscher, D.

Publikováno v: In Annals of Oncology January 2022 33(1):67-79

Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331☆

Autor: Spigel, D.R., Vicente, D., Ciuleanu, T.E., Gettinger, S., Peters, S., Horn, L., Audigier-Valette, C., Pardo Aranda, N., Juan-Vidal, O., Cheng, Y., Zhang, H., Shi, M., Luft, A., Wolf, J., Antonia, S., Nakagawa, K., Fairchild, J., Baudelet, C., Pandya, D., Doshi, P., Chang, H., Reck, M.

Publikováno v: In Annals of Oncology May 2021 32(5):631-641

Nivolumab plus ipilimumab versus carboplatin-based doublet as first-line treatment for patients with advanced non-small-cell lung cancer aged ≥70 years or with an ECOG performance status of 2 (GFPC 08-2015 ENERGY): a randomised, open-label, phase 3 study.

Autor: Léna H; Service de Pneumologie, Centre Hospitalier Universitaire de Rennes, Université Rennes 1, INSERM, UMR_S 1242, Centre Eugène Marquis, Rennes, France. Electronic address: herve.lena@chu-rennes.fr., Greillier L; Multidisciplinary Oncology and Therapeutic Innovations, Aix-Marseille University, APHM, INSERM, CNRS, CRCM, Hôpital Nord, Marseille, France., Cropet C; Unité de Biostatistique-Direction de la Recherche et de l'Innovation, Centre Léon Bérard, Lyon, France., Bylicki O; Hôpital d'Instruction des Armées Desgenettes, Lyon, France., Monnet I; Service de Pneumologie, Centre Hospitalier Intercommunal Créteil, Créteil, France., Audigier-Valette C; Service de Pneumologie, Orientation Oncologique, Hôpital Sainte-Musse, Toulon, France., Falchero L; Service de Pneumologie et Cancérologie Thoracique, Hôpitaux Nord-Ouest, Villefranche sur Saône, France., Vergnenègre A; Unité d'Oncologie Thoracique, Centre Hospitalier Universitaire Dupuytren, Limoges, France., Demontrond P; Centre de Lutte Contre le Cancer François Baclesse, Caen, France., Geier M; Institut de Cancérologie et Imagerie, Hopital Cavale Blanche Centre Hospitalier Universitaire Brest, Brest, France., Guisier F; Service de Pneumologie, Centre Hospitalier Universitaire Rouen, Rouen, France., Hominal S; Service de Pneumologie, Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy, France., Locher C; Service de Pneumologie, Grand Hôpital de l'Est Francilien (Meaux), Meaux, France., Corre R; Centre Hospitalier de Cornouaille, Service de Pneumologie, Quimper, France., Chouaid C; Service de Pneumologie, Centre Hospitalier Intercommunal Créteil, Créteil, France., Ricordel C; Service de Pneumologie, Centre Hospitalier Universitaire de Rennes, Université Rennes 1, INSERM, UMR_S 1242, Centre Eugène Marquis, Rennes, France.

Publikováno v: The Lancet. Respiratory medicine [Lancet Respir Med] 2024 Oct 29. Date of Electronic Publication: 2024 Oct 29.